Home » FDA Says Anemia Drug Withdrawl Wasn’t For Safety
FDA Says Anemia Drug Withdrawl Wasn’t For Safety
Manufacturer Hospira’s 2005 withdrawal of its leucovorin injection was not done for effectiveness or safety reasons, the FDA said, paving the way for new ANDAs on the generic anemia drug.
Generic Line
Drugs Submissions and ApprovalsGeneric Line
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct